Enigma Biomedical USA, Inc. Announces a Collaboration to Apply Novel 4R PET Imaging Biomarkers to CTE Research
Enigma Biomedical USA, Inc. (EB USA) today announced that it is starting a collaboration with the Boston University Chronic Traumatic Encephalopathy (CTE) Center and the Concussion Legacy Foundation.
The Valdosta Daily Times9d
Javon Longieliere places 6th at 2025 World Photographic Cup
Valdosta photographer Javon Longieliere placed sixth in the 2025 World Photographic Cup in the Wedding Photojournalism ...
Medical Device Network on MSN11d
Leadoptik and Stanford Medicine to explore imaging in lung biopsy procedures
Leadoptik has entered a research partnership with Stanford Medicine, focusing on AI-enhanced real-time optical imaging usage ...
Canon Medical Systems USA Announces FDA Clearance and Market Availability of Adora DRFi: An Automated Hybrid Solution for Radiography and Fluoroscopy
The Adora DRFi seamlessly combines static and dynamic radiography with low-dose fluoroscopy, enhancing workflow efficiency and equipment utilization for healthcare providers. Each functional aspect of ...
Morningstar10d
Enigma Biomedical USA, Inc. Announces Candidate Selection of Novel 4R Tau PET Imaging Biomarkers
Enigma Biomedical USA, Inc. (EB USA) today announced that it has selected two (2) four-repeat tau (4R Tau) protein PET imaging biomarkers to advance into Phase 1 (Ph1) studies. Previously ...